Tokyo, Dec. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060067) titled 'Safety and Efficacy of Fiducial Marker and Hydrogel Spacer Placement in Carbon-Ion Radiotherapy for Prostate Cancer' on Dec. 12.
Study Type:
Observational
Primary Sponsor:
Institute - National Institutes for Quantum Science and Technology, QST Hospital
Condition:
Condition - prostate cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the safety of fiducial marker and hydrogel spacer placement in carbon-ion radiotherapy for prostate cancer.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not appli...